Previous 10 | Next 10 |
Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a 2018 district court ruling that barred Minerva from challenging the validity of the patent rights it assigned to Hologic. “We are pleased that the U.S. Court of ...
Active Motif Incorporated Licenses Targeted Transposition to Diagenode S.A. Technology Canada NewsWire CARLSBAD, Calif. , July 31, 2022 /CNW/ -- Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precis...
Hologic, Inc. (HOLX) Q3 2022 Results Earnings Conference Call July 28, 2022, 04:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Off...
Image source: The Motley Fool. Hologic (NASDAQ: HOLX) Q3 2022 Earnings Call Jul 27, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Hologic (HOLX) Q3 2022 Earnings Call Transcript
We believe the healthcare sector's strong growth momentum with average revenue growth of 3.8% QoQ indicates a positive outlook, with the equipment industry forecasted at a market CAGR of 5.5%. For the healthcare equipment industry, we believe the outlook is supported by the average gu...
Hologic press release ( NASDAQ: HOLX ): Q3 Non-GAAP EPS of $0.95 beats by $0.25 . Revenue of $1B (-14.5% Y/Y) beats by $103.29M . Global Organic Molecular Diagnostics ex-COVID-19 Revenue Grows Over 20% in Constant Currency. Company Again Increases Full-Year...
– Revenue of $1.003 Billion, GAAP Diluted EPS of $0.90, and Non-GAAP Diluted EPS of $0.95 All Significantly Ahead of Expectations – – Global Organic Molecular Diagnostics ex-COVID-19 Revenue Grows Over 20% in Constant Currency – – Company Again...
Hologic ( NASDAQ: HOLX ) is scheduled to announce FQ3 earnings results on Wednesday, July 27th, after market close. The consensus EPS estimate is $0.70 and consensus revenue estimate is $896.71M. Over the last 2 years, HOLX has beaten EPS estimates 88% of the time ...
Although the healthcare sector has largely resisted this year's downward pressure, it is likely to succumb as pressure increases. Healthcare stocks have a well-deserved reputation for cyclical defense, but they are more likely to underperform in "secular" bear markets. Healthcare ...
BofA Securities has downgraded diagnostics products and medical imaging systems company Hologic ( NASDAQ: HOLX ) citing headwinds from supply chain issues, foreign exchange, and COVID-19. The firm also cut its price target to $75 from $81 (~6% upside based on Tue...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...